Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer

• David D’Andrea,
• Beat Foerster,
• Surena F. Matin,
• Ja H. Ku,
• Tim Muilwijk,
• Leonardo L. Monteiro,
• Ross Liao,
• Firas G. Petros,
• Philippe E. Spiess,
• Trinity J. Bivalacqua,
• Kees Hendricksen,
• Bas W.G. van Rhijn,
• Ahmad Shabsigh,
• Alberto Briganti,
• Steven Joniau,
• Wassim Kassouf,
• Phillip M. Pierorazio,
• Vitaly Margulis,
• Andrea Necchi,
• Shahrokh F. Shariat

Affiliations

David D’Andrea

Department of Urology, Medical University of Vienna, Vienna, Austria

Beat Foerster

Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Kantonsspital Winterthur, Winterthur, Switzerland

Surena F. Matin

Department of Urology, MD Anderson Cancer Center, Houston, TX, USA

Ja H. Ku

Department of Urology, Seoul National University Hospital, Seoul, South Korea

Tim Muilwijk

Department of Urology, University Hospitals Leuven, Leuven, Belgium

Leonardo L. Monteiro

Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada

Ross Liao

Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA

Firas G. Petros

Department of Urology and Kidney Transplant, The University of Toledo Medical Center and Eleanor N. Dana Cancer Center, Toledo, OH, USA

Philippe E. Spiess

Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA

Trinity J. Bivalacqua

Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA

Kees Hendricksen

Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Bas W.G. van Rhijn

Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Ahmad Shabsigh

Department of Urology, Ohio State University, Columbus, OH, USA

Alberto Briganti

Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy

Steven Joniau

Department of Urology, University Hospitals Leuven, Leuven, Belgium

Wassim Kassouf

Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada

Phillip M. Pierorazio

Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA

Vitaly Margulis

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Andrea Necchi

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Shahrokh F. Shariat

Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Urology, University of Jordan, Amman, Jordan; Corresponding author. Department of Urology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Tel.: +43 1 404002615; Fax: +43 1 404002332.